- Filed
- May 11, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 125.09M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 124.69M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 70.62M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $19.36M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$27.04M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$25.64M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $669.51M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $714.17M |
| Cash And Equivalents restated | Q1 2026 · Mar 31, 2025 | $19.14M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $816.18M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $861.3M |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $102.55M |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | $108.86M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $34.24M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $14.65M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $38.55M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $16.34M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $698.57M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $748.55M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $854.72M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $877.64M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.39 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.12 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.39 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.12 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $3.35M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $1.84M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$48.63M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$8.21M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$56.56M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$14.96M |